Apellis Pharmaceuticals (APLS) Inventory Average: 2021-2025
Historic Inventory Average for Apellis Pharmaceuticals (APLS) over the last 4 years, with Sep 2025 value amounting to $121.9 million.
- Apellis Pharmaceuticals' Inventory Average fell 10.96% to $121.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $121.9 million, marking a year-over-year decrease of 10.96%. This contributed to the annual value of $113.9 million for FY2024, which is 1.86% down from last year.
- Per Apellis Pharmaceuticals' latest filing, its Inventory Average stood at $121.9 million for Q3 2025, which was up 19.83% from $101.7 million recorded in Q2 2025.
- In the past 5 years, Apellis Pharmaceuticals' Inventory Average ranged from a high of $157.0 million in Q2 2024 and a low of $2.7 million during Q3 2021.
- Over the past 3 years, Apellis Pharmaceuticals' median Inventory Average value was $101.7 million (recorded in 2025), while the average stood at $114.4 million.
- Its Inventory Average has fluctuated over the past 5 years, first soared by 1,900.81% in 2022, then plummeted by 46.73% in 2025.
- Over the past 5 years, Apellis Pharmaceuticals' Inventory Average (Quarterly) stood at $9.0 million in 2021, then skyrocketed by 709.81% to $72.7 million in 2022, then soared by 68.36% to $122.5 million in 2023, then fell by 17.33% to $101.2 million in 2024, then decreased by 10.96% to $121.9 million in 2025.
- Its Inventory Average was $121.9 million in Q3 2025, compared to $101.7 million in Q2 2025 and $81.9 million in Q1 2025.